143 related articles for article (PubMed ID: 1479739)
1. A stable metabolite, Arg-Pro-Pro-Gly-Phe, of bradykinin in the degradation pathway in human plasma.
Shima C; Majima M; Katori M
Jpn J Pharmacol; 1992 Oct; 60(2):111-9. PubMed ID: 1479739
[TBL] [Abstract][Full Text] [Related]
2. Increase in the kinin levels in the bronchial washings after intravenous injection of leukotriene C4 in guinea pigs.
Majima M; Jin HY; Katori M; Sunahara N
Agents Actions Suppl; 1992; 38 ( Pt 3)():467-74. PubMed ID: 1462880
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P.
Ward PE; Chow A; Drapeau G
Biochem Pharmacol; 1991 Jul; 42(4):721-7. PubMed ID: 1651078
[TBL] [Abstract][Full Text] [Related]
4. Isolation of brain endopeptidases: influence of size and sequence of substrates structurally related to bradykinin.
Oliveira EB; Martins AR; Camargo AC
Biochemistry; 1976 May; 15(9):1967-74. PubMed ID: 5120
[TBL] [Abstract][Full Text] [Related]
5. Studies of the digestion of bradykinin, Lys-bradykinin, and des-Arg9-bradykinin by angiotensin converting enzyme.
Sheikh IA; Kaplan AP
Biochem Pharmacol; 1986 Jun; 35(12):1951-6. PubMed ID: 3013204
[TBL] [Abstract][Full Text] [Related]
6. Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation.
Raymond P; Drapeau G; Raut R; Audet R; Marceau F; Ong H; Adam A
J Immunol Methods; 1995 Mar; 180(2):247-57. PubMed ID: 7714339
[TBL] [Abstract][Full Text] [Related]
7. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis.
Butt SK; Dawson LG; Hall JM
Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687
[TBL] [Abstract][Full Text] [Related]
8. Degradation of bradykinin and its metabolites by rat brain synaptic membranes.
Orawski AT; Simmons WH
Peptides; 1989; 10(5):1063-73. PubMed ID: 2608554
[TBL] [Abstract][Full Text] [Related]
9. Detection of the degradation products of bradykinin by enzyme immunoassays as markers for the release of kinin in vivo.
Majima M; Sunahara N; Harada Y; Katori M
Biochem Pharmacol; 1993 Feb; 45(3):559-67. PubMed ID: 8442755
[TBL] [Abstract][Full Text] [Related]
10. Kinin metabolism in the perfused ventilated rat lung. I: Bradykinin metabolism in a system modeling the normal, uninjured lung.
Baker CR; Little AD; Little GH; Canizaro PC; Behal FJ
Circ Shock; 1991 Jan; 33(1):37-47. PubMed ID: 2009602
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
Vianna RM; Calixto JB
Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
[TBL] [Abstract][Full Text] [Related]
12. Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema.
Blais C; Rouleau JL; Brown NJ; Lepage Y; Spence D; Munoz C; Friborg J; Geadah D; Gervais N; Adam A
Immunopharmacology; 1999 Sep; 43(2-3):293-302. PubMed ID: 10596866
[TBL] [Abstract][Full Text] [Related]
13. Serum interspecies differences in metabolic pathways of bradykinin and [des-Arg9]BK: influence of enalaprilat.
Décarie A; Raymond P; Gervais N; Couture R; Adam A
Am J Physiol; 1996 Oct; 271(4 Pt 2):H1340-7. PubMed ID: 8897926
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma.
Cyr M; Lepage Y; Blais C; Gervais N; Cugno M; Rouleau JL; Adam A
Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H275-83. PubMed ID: 11406494
[TBL] [Abstract][Full Text] [Related]
15. Identification of endogenous Des-Arg9-[Hyp3]-bradykinin in human plasma with post-source-decay matrix-assisted laser desorption/ionization mass spectrometry.
Schlüter H; Mentrup D; Gross I; Meyer HE; Spengler B; Kaufmann R; Zidek W
Anal Biochem; 1997 Mar; 246(1):15-9. PubMed ID: 9056177
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of Sar-[D-Phe8]des-Arg9-bradykinin, a metabolically protected agonist of B1 receptor for kinins, in the anesthetized rabbit pretreated with a sublethal dose of bacterial lipopolysaccharide.
Audet R; Rioux F; Drapeau G; Marceau F
J Pharmacol Exp Ther; 1997 Jan; 280(1):6-15. PubMed ID: 8996175
[TBL] [Abstract][Full Text] [Related]
17. Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins.
Drapeau G; deBlois D; Marceau F
J Pharmacol Exp Ther; 1991 Dec; 259(3):997-1003. PubMed ID: 1662280
[TBL] [Abstract][Full Text] [Related]
18. A useful and sensitive method for demonstration of the involvement of either kallikrein-kinin system in pathological states.
Majima M; Sunahara N; Uchida Y; Katori M
Agents Actions Suppl; 1992; 38 ( Pt 1)():441-8. PubMed ID: 1466291
[TBL] [Abstract][Full Text] [Related]
19. Effect of des arginine9-bradykinin and other bradykinin fragments on the synthesis of prostacyclin and the binding of bradykinin by vascular cells in culture.
Cahill M; Fishman JB; Polgar P
Agents Actions; 1988 Jul; 24(3-4):224-31. PubMed ID: 3051930
[TBL] [Abstract][Full Text] [Related]
20. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin.
Tropea MM; Gummelt D; Herzig MS; Leeb-Lundberg LM
J Pharmacol Exp Ther; 1993 Feb; 264(2):930-7. PubMed ID: 8382284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
